Chemist carrying out an experiment

Strathclyde Institute of Pharmacy & Biomedical Sciences

Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) is a leading centre for research focused on new medicines, better medicines and better use of medicines.

SIPBS is a top UK School of Pharmacy delivering an accredited four year MPharm degree together with a range of accredited BSc and MSci degrees in the Biomedical Sciences.

We offer a number of taught Masters degrees and have a thriving postgraduate research community undertaking PhD, MRes, MPhil, and DPharm higher degrees.

SIPBS is committed to supporting equality and diversity for all our staff and students.

Discover more about pharmacy & biomedical sciences

SIPBS rank 1st in the UK for Pharmacology and Pharmacy

We are 13th in the UK and 4th in Scotland for Biological Sciences

Meet our people

Cancer Research UK Formulation Unit

Cancer Research UK Formulation Unit

This cutting-edge unit develops putative anti-cancer drugs to a level suitable for Phase I and II clinical trials.  Expertise ranges from drug characterisation, to formulation development and regulatory requirements. ?Find out more about the unit.

Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation (CMAC)

CMAC tubes filled with purple dye

CMAC works closely with our industry partners with a shared vision to accelerate the adoption of continuous manufacturing processes, systems and plants for the production of high-value chemical products to higher quality, at lower cost and more sustainably.

Industrial Biotechnology Innovation Centre (IBioIC)

flasks and tubes in lab

IBioIC are specialists in the industrial biotechnology (IB) sector, with a deep embedded knowledge and the technical expertise to help stimulate the growth and success of the IB industry in Scotland by connecting the dots between industry, academia and government.



CORE is a four year Marie Sk?odowska-Curie Innovative Training Network (ITN) on Continuous Resolution and Deracemization of Chiral Compounds by Crystallization which started on the 1 October 2016. CORE brings together 8 beneficiary partners and 7 associate partners from 6 European countries resulting in an unparalleled combination of chirality, synthesis and crystallization training and research covering the areas of Chemical Engineering, Chemistry and Applied Physics.